Three decades of experience in the surgical multi-modality management of pleural mesothelioma

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 3, 2010, Pages 552-556

  Luckraz, Heyman ^a   Rahman, Mesbah ^b   Patel, Nishith ^b   Szafranek, Adam ^b   Gibbs, Allen R ^b   Butchart, Eric G ^b  

^a NEW CROSS HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Multi modality treatment; Pleural mesothelioma

Indexed keywords

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DECORTICATION; FEMALE; FOLLOW UP; HUMAN; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PLEURA BIOPSY; PLEURA MESOTHELIOMA; PLEURECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

AGED; CHEMOTHERAPY, ADJUVANT; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 76449091250     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.07.032     Document Type: Article

References (18)

1. Hodgson J.T., McElvenny D.M., Darnton A.J., Price M.J., and Peto J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 92 (2005) 587-593
2. Butchart E.G., Ashcroft T., Barnsley W.C., and Holden M.P. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax 31 (1976) 15-24
3. Vogelzang N.J., Rusthoven J.J., Symanowski J., Denham C., Kaukel E., Ruffie P., Gatzemeier U., Boyer M., Emri S., Manegold C., Niyikiza C., and Paoletti P. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 (2003) 2636-2644
4. Metintas M., Ak G., Erginel S., Alatas F., Yildirim H., Kurt E., and Metintas S. Retrospective analysis of malignant pleural mesothelioma patients treated either with chemotherapy or best supportive care between 1990 and 2005. A single institution experience. Lung Cancer 55 (2007) 379-387
5. Waite K., and Gilligan D. The role of radiotherapy in the treatment of malignant pleural mesothelioma. Clin Oncol 19 (2007) 182e-187
6. Halstead J.C., Lim E., Venkateswaran R.M., Charman S.C., Goddard M., and Ritchie A.J. Improved survival with VATS pleurectomy/decortication in advanced malignant mesothelioma. EJSO 31 (2005) 314-320
7. Martin-Ucar A.E., Edwards J.G., Rengajaran A., Muller S., and Waller D.A. Palliative surgical debulking in malignant mesothelioma: predictors of survival and symptom control. Eur J Cardiothorac Surg 120 (2001) 1117-1121
8. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., Richards W.G., Strauss G.M., Corson J.M., DeCamp Jr. M.M., Swanson S.J., Bueno R., Lukanich J.M., Baldini E.H., and Mentzer S.J. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117 (1999) 54-65
9. Sugarbaker D.J. Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol 1 2 (2006) 175-176
10. Martin-Ucar A.E., Nakas A., Edwards J.G., and Waller D.A. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma. Eur J Cardiothorac Surg 31 (2001) 765-771
11. Weder W., Stahel R.A., Bernhard J., Bodis S., Vogt P., Ballabeni P., Lardinois D., Betticher D., Schmid R., Stupp R., Ris H.B., Jermann M., Mingrone W., Roth A.D., Spiliopoulos A., and Swiss Group for Clinical Cancer Research. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 18 (2007) 1196-1202
12. Lee T.T., Everett D.L., Shu H.G., Jahan T.M., Roach III M., Speight J.L., Cameron R.B., Phillips T.L., Chan A., and Jablons D.M. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 124 (2002) 1183-1189
13. Borasio P., Berruti A., Bille A., Lausi P., Levra M.G., Giardino R., and Ardissone F. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardiothorac Surg 33 (2008) 307-313
14. Rice D.C., Stevens C.W., Correa A.M., Vaporciyan A.A., Tsao A., Forster K.M., Walsh G.L., Swisher S.G., Hofstetter W.L., Mehran R.J., Roth J.A., Liao Z., and Smythe W.R. Outcomes of extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 84 (2007) 1685-1693
15. Flores RM, Pass H, Venkatraman E, Dycoco J, Bains M, Rusch VW. Extrapleural pneumonectomy (EPP) versus pleurectomy/decortication (P/D) in the surgical management of malignant pleural mesothelioma (MPM): results in 663 patients. Presented at the AATS, 87th Annual Meeting Washington 2007.
16. Flores R.M., Zakowski M., Venkaraman E., Krug L., Rosenzwieg K., Dycoco J., Lee C., Yeoh C., Bains M., and Rusch V. Prognostic factors in the treatment of malignant mesothelioma at a large tertiary referral centre. J Thorac Oncol 2 (2007) 957-965
17. Rea F., Marulli G., Bortolotti L., Breda C., Favaretto A.G., Loreggian L., and Sartori F. Induction chemotherapy, extrapleural pneumonectomy (EPP), and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results. Lung Cancer 57 (2007) 89-95
18. Schipper P.H., Nichols F.C., Thomse K.M., Deschamps C., Cassivi S.D., Allen M.S., and Pairolero P.C. Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg 85 (2008) 257-264